The deal range was $6.00-$6.50. TD Cowen, Cantor Fitzgerald, LifeSci Capital, Oppenheimer and Scotiabank acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TARA:
- Closing Bell Movers: Oracle slips 8% after Q2 earnings miss, disappointing guide
- Protara Therapeutics announces common stock offering, no amount given
- Protara Therapeutics Reports Promising Phase 2 Trial Results
- Protara Therapeutics announces results from Phase 2 ADVANCE-2 trial
- Protara Therapeutics to hold a conference call
Questions or Comments about the article? Write to editor@tipranks.com